|
The prevalence of
co-existing substance misuse and psychiatric disorder (dual
diagnosis, comorbidity) has increased over the past decade, and the
indications are that it will continue to rise.
There have simultaneously been unprecedented developments in the
pharmacological treatment of alcohol, opiate and nicotine misuse.
Here we evaluate the evidence on the use of some of these
treatments in dual diagnosis (with psychotic, mood and anxiety
disorders). The evidence base is limited by the exclusion of mental
illness when pharmacological agents for substance misuse are
evaluated and vice versa.
We set the available information within the context of the
psychosocial management of comorbid substance misuse and mental
illness, and the framework for service delivery recommended by UK
national policy.
The module will take you through some of the key points with
regard to:
It also offers case studies, toolkits and manuals and a reading
list with web links to the original articles wherever possible.
Start
the module
|
Download take-home notes to print and
annotate
|